Stocks · US
RGEN
XNAS
Repligen Corp
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E257.46x
P/B5.06x
P/S13.62x
EPS$0.74
ROE1.97%
ROA1.41%
Dividend yield0.00%
EV/EBITDA70.30x
Debt/Equity0.26
Free cash flow$112M
Returns and 52-week range
1W-10.13%
1M+4.33%
3M+27.25%
6M+51.67%
1Y+17.57%
YTD+6.39%
52W high$198.87
52W low$100.99
From 52W high-12.07%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 쿠퍼 | $10.8B | 18.93 | 1.30 | -18.91% |
| Avantor, Inc. | $10.7B | — | 1.90 | +3.07% |
| Vaxcyte, Inc. Common Stock | $11.0B | — | 3.98 | +9.06% |
| 유니버설 헬스 서비시스 | $10.4B | 6.80 | 1.38 | +4.38% |
| 이뮤니티바이오 | $11.0B | — | — | +19.93% |
| GLOBUS MEDICAL INC | $10.3B | 19.20 | 2.16 | -2.38% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.